Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*. Biol Blood Marrow Transplant, 20, 1566-1572. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24972249. (2014).
Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials. Clin Trials, 5, 607-616. presented at the 12/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19029209. (2008).